Arpita Chowdhury, Ph.D. Email & Phone Number
Who is Arpita Chowdhury, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Arpita Chowdhury, Ph.D. is listed as Head of Research and Strategy at myriamed GmbH, a with 7 employees, based in Dresden, Saxony, Germany. AeroLeads shows a matched LinkedIn profile for Arpita Chowdhury, Ph.D..
Arpita Chowdhury, Ph.D. previously worked as Senior Scientist / Biology lead at Dewpoint Therapeutics and Consultant at Dialectica. Arpita Chowdhury, Ph.D. holds Doctorate Of Philosophy (Phd), Cardiovascular Basic Research And Molecular Medicine from Medizinische Hochschule Hannover.
Email format at myriamed GmbH
This section adds company-level context without repeating Arpita Chowdhury, Ph.D.'s masked contact details.
Review company-level records connected to Arpita Chowdhury, Ph.D. before choosing the right outreach path.
About Arpita Chowdhury, Ph.D.
My curiosity and commitment to understanding and advancing cardiovascular (CV) disease researchhave shaped my 13+ year journey, focusing on drug discovery. As a seasoned scientist, I embrace new challenges with continuous learning and weaving strategic approaches to move projects from early discovery through the preclinical stage. My strengths lie in driving innovation, crafting solutions, maintaining results-driven mindset and leading matrixed cross-functional teams with compassionate leadership. I am eager to collaborate on purpose-driven projects and with teams to deliver impactful outcomes that make a meaningful difference in the field.
Arpita Chowdhury, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Arpita Chowdhury, Ph.D. work experience
A career timeline built from the work history available for this profile.
Senior Scientist / Biology Lead
I work with leading discovery projects in cardiovascular diseases advancing them to PCC and accelerating translational research. Core competencies:Drug Discovery • Accelerated small molecule drug discovery CV programs, from target discovery, hit validation, candidate identification to lead optimization.Translational research• Established and integrated translational and preclinical animal models for PCC.• Implemented functional assays with invitro… Show more I work with leading discovery projects in cardiovascular diseases advancing them to PCC and accelerating translational research. Core competencies:Drug Discovery • Accelerated small molecule drug discovery CV programs, from target discovery, hit validation, candidate identification to lead optimization.Translational research• Established and integrated translational and preclinical animal models for PCC.• Implemented functional assays with invitro and organoid disease models.• Coordinated PK/PD modeling in close collaboration with DMPK and ADME experts.• Advanced biomarker identification through a multi-omics approach in collaboration with cross- functional teams. Technologies:• Leveraged emerging technologies, including CRISPR, high throughput functional assays in iPS- cardiomyocytes, high throughput screening and omics platform. Stakeholder engagement:• Experienced in engaging with internal and external stakeholders, including pharma partners, collaborators, KOLs, CROs, academic labs and C-suite executives.Project management and team leadership:• Lead and bring together cross-functional scientific teams for effective collaboration and productivity, pivotal to preclinical acceleration. • Collaborated with multidisciplinary teams for achieving project targets ensuring timelines and goals are met. Show less
Consultant
Review Editor
Young-Dzhk Site Spokesperson-Göttingen Site
Postdoctoral Research Scientist
In Prof. Peter Rehling's group. My research focus has been elucidation of molecular pathways in mitochondrial cardiomyopathies. Projects headed:1. ROS induced manifestation of cardiac hypertrophy in Barth syndrome (BTHS) models. Highlight: - Identification of ROS induced HIF1a and NFkB disease signaling pathway in iPS-derived Cardiomyocytes and shTAZ Mouse models for BTHS.2. Role of metabolic pathway switching in the progression… Show more In Prof. Peter Rehling's group. My research focus has been elucidation of molecular pathways in mitochondrial cardiomyopathies. Projects headed:1. ROS induced manifestation of cardiac hypertrophy in Barth syndrome (BTHS) models. Highlight: - Identification of ROS induced HIF1a and NFkB disease signaling pathway in iPS-derived Cardiomyocytes and shTAZ Mouse models for BTHS.2. Role of metabolic pathway switching in the progression of cardiac pathology in BTHS. Highlights: - Generation and establishment of CRISPR/Cas mediated patient-mutation Knock-in mouse model for BTHS. - Elucidation of the metabolic shift from FAO to Glycotic pathways in mouse heart and iPS- derived Cardiomyocytes resulting to cardiac failure. 3. MCU mediated mitochondrial calcium signaling in Coa6 patients derived iPS-cardiomyocytes. Highlights: - Generation of CRISPR/Cas mediated heart specific conditional KO mouse model for Coa6. - Elaborating calcium mediated signaling pathways leading to cardiac hypertrophy in mouse model and patient derived iPS-cardiomyocytes. Show less
Phd Student
Thesis Title: Fibulin-6 and PTPR-σ: The cell-matrix anchors in adverse myocardial remodeling• Gained expertise in MI and TAC surgeries in mouse heart. • Extensive animal handling, dissections, tissue harvesting, organ perfusion.• Developed skills in cardiac tissue histology methods and microscopy (Fluorescence and confocal) • Molecular biology techniques (Western blotting, RT-PCR, ELISA assays).• Extensive cell culture experience including, primary cardiomyocyte and… Show more Thesis Title: Fibulin-6 and PTPR-σ: The cell-matrix anchors in adverse myocardial remodeling• Gained expertise in MI and TAC surgeries in mouse heart. • Extensive animal handling, dissections, tissue harvesting, organ perfusion.• Developed skills in cardiac tissue histology methods and microscopy (Fluorescence and confocal) • Molecular biology techniques (Western blotting, RT-PCR, ELISA assays).• Extensive cell culture experience including, primary cardiomyocyte and fibroblast isolation, immortalized mammalian cell line, their maintenance and experimentation.• Have established immortalized cardiac fibroblasts using 3T3 method. • Have been instrumental in creating primary cardiac fibroblast derived matrix for 3D cardiomyocyte culture. • Reviewed several manuscripts and have published 2 first author and 2 co-author research articles. Show less
Project Assistant (Jrf)
Project 1: Genetic Analysis of HIV-1 subtypes Circulating in North India.•Genomic DNA isolation, PCR validation and sequence analysis from patient samples to find out the novel HIV-1 subtypes. Project 2: Combination of RNAi technology with novel catalytic DNAzyme and aptamers against HIV-1 genes.
Arpita Chowdhury, Ph.D. education
Doctorate Of Philosophy (Phd), Cardiovascular Basic Research And Molecular Medicine
Master Of Science (M.Sc.), Molecular And Human Genetics
Bachelor Of Science (B.Sc.), Biotechnology
High School
Frequently asked questions about Arpita Chowdhury, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Arpita Chowdhury, Ph.D. work for?
Arpita Chowdhury, Ph.D. works for myriamed GmbH.
What is Arpita Chowdhury, Ph.D.'s role at myriamed GmbH?
Arpita Chowdhury, Ph.D. is listed as Head of Research and Strategy at myriamed GmbH.
Where is Arpita Chowdhury, Ph.D. based?
Arpita Chowdhury, Ph.D. is based in Dresden, Saxony, Germany while working with myriamed GmbH.
What companies has Arpita Chowdhury, Ph.D. worked for?
Arpita Chowdhury, Ph.D. has worked for Myriamed Gmbh, Dewpoint Therapeutics, Dialectica, Frontiers In Cell And Developmental Biology, and Dzhk Deutsches Zentrum Für Herz-Kreislauf-Forschung E. V..
Who are Arpita Chowdhury, Ph.D.'s colleagues at myriamed GmbH?
Arpita Chowdhury, Ph.D.'s colleagues at myriamed GmbH include Celine Klenner.
How can I contact Arpita Chowdhury, Ph.D.?
You can use AeroLeads to view verified contact signals for Arpita Chowdhury, Ph.D. at myriamed GmbH, including work email, phone, and LinkedIn data when available.
What schools did Arpita Chowdhury, Ph.D. attend?
Arpita Chowdhury, Ph.D. holds Doctorate Of Philosophy (Phd), Cardiovascular Basic Research And Molecular Medicine from Medizinische Hochschule Hannover.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial